Journal of Clinical Microbiology, November 1999, p. 3681-3687, Vol. 37, No. 11
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Genotypic and Phenotypic Characterization of
"Streptococcus milleri" Group Isolates from a Veterans
Administration Hospital Population
Jill E.
Clarridge III,1,2,3,*
Cheryl
Osting,3
Mehri
Jalali,1
Janet
Osborne,3 and
Michael
Waddington4
Department of
Pathology1 and Department of
Microbiology and Immunology,2 Baylor
College of Medicine, and Pathology and Laboratory Medicine Service,
Veterans Affairs Medical Center,3
Houston, Texas, and MIDI Labs Inc., Newark,
Delaware4
Received 25 May 1999/Returned for modification 8 July 1999/Accepted 9 August 1999
 |
ABSTRACT |
Because identification of the species within the "Streptococcus
milleri" group is difficult for the clinical laboratory as the
species share overlapping phenotypic characteristics, we wished to
confirm biochemical identification with identification by 16S rRNA gene
sequence analysis. Ninety-four clinical isolates previously identified
as the "Streptococcus milleri" group were reclassified as S. anginosus, S. constellatus, or S. intermedius with the API 20 Strep system (bioMerieux Vikek,
Hazelton, Mo.) and the Fluo-card (Key Scientific, Round Rock, Tex.). In
addition, we determined the Lancefield group, hemolysis, colony size,
colony texture, repetitive extragenic palindromic PCR (rep-PCR)
pattern, and cellular fatty acid (CFA) profile (MIDI, Newark, Del.).
16S rRNA gene sequence analysis with 40 selected representative strains
showed three distinct groups, with S. constellatus and
S. intermedius found to be more closely related to each
other than to S. anginosus, and further distinguished a
biochemically distinct group of urogenital isolates within the S. anginosus group of isolates. Except for strains unreactive with
the Fluo-card (8%), all S. anginosus and S. intermedius strains identified by sequencing were similarly identified by biochemical testing. However, 23% of the selected S. constellatus isolates identified by sequencing (9% of
all S. constellatus isolates) would have been identified as
S. anginosus or S. intermedius by biochemical
tests. Although most S. anginosus strains formed one unique
cluster by CFA analysis and most S. constellatus strains
showed similar rep-PCR patterns, neither method was sufficiently
dependable for identification. Whereas Lancefield group or lactose
fermentation did not correspond to sequence or biochemical type,
S. constellatus was most likely to be beta-hemolytic and
S. intermedius was most likely to have a dry colony type.
The most frequent isolate in our population was S. constellatus, followed by S. anginosus. There was an
association of S. anginosus with a gastrointestinal or
urogenital source, and there was an association of S. constellatus and S. intermedius with both the
respiratory tract and upper-body abscesses.
 |
INTRODUCTION |
Members of the
"Streptococcus milleri" group, which for a brief period
were considered a single species loosely synonymous with S. anginosus (5, 15), are now separated into three
distinct species: S. anginosus, S. constellatus,
and S. intermedius (16, 17). However, because
many phenotypic tests for the characterization of the species show
considerable overlap, it has been difficult for the clinical laboratory
to correctly classify isolates (9). Recently, in an
excellent study, Whiley et al. (19) found that seven
biochemical tests could separate the "S. milleri" group into the S. anginosus, S. constellatus, and
S. intermedius groups. Flynn and Ruoff (6)
reported that the Fluo-card (Key Scientific, Round Rock, Tex.), which
uses three of these substrates to test for
-D
fucosidase,
-D-glucosidase, and
-D-glucosidase activity, when used in conjunction with
other tests, correctly identified over 97% of the S. anginosus and S. constellatus species and 88% of the
S. intermedius species (6). By use of these
better identification schemes, several recent reports associated
species with site of isolation or disease. However, the data from
different institutions and for different patient populations have shown
variations in species distribution and overlapping clinical
associations (1, 2, 6, 8, 13, 18). In this paper, we seek a
closer association of phenotype, genotype, and site of isolation for "S. milleri" group isolates from a defined population
(adult male patients) by confirming the biochemical identification by
16S rRNA gene sequencing.
 |
MATERIALS AND METHODS |
Organisms.
All clinical strains were obtained from the
Microbiology Laboratory of the Houston Veterans Affairs Medical Center.
We examined 101 clinical isolates from our stock collection. The
isolates either were identified by the API Rapid Strep test as the
S. milleri group or were older isolates identified by
nonspecified methods as S. anginosus, S. constellatus, S. intermedius, Streptococcus group F, or small-colony Streptococcus groups C or G. All
but seven of these isolates were confirmed to be in the "S.
milleri" group (characteristic Streptococcus
morphology, catalase negativity, and Lancefield group F or
Voges-Proskauer test positive, arginine positive, and sorbitol
negative). A second group included strains similar to the "S.
milleri" group either by biochemical characterization or by
colony morphology, such as S. bovis, S. sanguis,
and S. dysgalactiae subsp. equisimilis (which can
be Lancefield group C or G). Reference stock strains included four
American Type Culture Collection (ATCC) strains (ATCC 27838, ATCC
33397, ATCC 9895, and ATCC 27335) which are described as the S. constellatus type strain, the S. anginosus type strain,
S. anginosus, and the S. intermedius type strain, respectively.
Biochemical and phenotypic characterization.
Hemolysis on
Columbia agar plates (BBL, Becton Dickinson, Cockeysville, Md.)
incubated anaerobically was assessed at 24 to 48 h. A strain that
is nonhemolytic around a single colony is often alpha-hemolytic in the
heavier areas, and a strain that is alpha-hemolytic around a single
colony is often beta-hemolytic in the heavier areas or becomes
beta-hemolytic with further incubation. For this study, strains were
called beta-hemolytic only if by 48 h beta-hemolysis was seen
around a single colony or complete clearing was seen under the heavier
areas. Lancefield grouping by latex agglutination (PathoDx; Diagnostic
Products Corp. Los Angeles, Calif.) and biochemical testing with the
API 20 Strep system (bioMerieux Vikek, Hazelton, Mo.) and the Fluo-card
(Key Scientific) were performed according to the manufacturers'
instructions. The Fluo-card measures the cleavage of three substrates.
We generated a biotype number by assigning numbers according to the
substrate's position on the card (1 =
-D-fucosidase activity, 2 =
-D-glucosidase activity, and 3 =
-D-glucosidase activity) and recording only positive
reactions to generate a biotype number. The isolate was identified as
S. intermedius if it had positive results for 1, 1 and 2, 1 and 3, or 1, 2, and 3, as S. anginosus if it had positive results for 2 or 2 and 3; and S. constellatus if it had
positive results for 3.
Cellular fatty acid (CFA) analysis.
Whole-cell fatty acids
were extracted and analyzed as reported previously (4),
except that to achieve sufficient growth the organisms were grown on
Columbia agar or Columbia colistin naladixic acid (CNA) agar (BBL,
Becton Dickinson) anaerobically for 48 h. Analysis was performed
with an automated Hewlett-Packard HP 5890 II Microbial Identification
System (MIDI Systems). Analysis of fatty acid peaks was achieved with
the manufacturer's software; however, the dendrogram was made only
with data for clinical and reference strains that we grew under similar conditions.
rep-PCR.
Previously described methods with conserved primers
corresponding to repetitive extragenic palindromic sequences in a
repetitive extragenic palindromic PCR (rep-PCR) were used
(4). For our usual protocol, the organisms were harvested
with a sterile swab and were resuspended in 0.9% sterile saline to a
turbidity that matched that of a 3.0 McFarland standard. The reaction
mixture consisted of 5.0 µl of 5× polymerase buffer, 2.5 µl of
dimethyl sulfoxide, 0.5 µl of each deoxynucleoside triphosphate (25 mM), 1 µl (50 pmol) of each primer, 4 µl of a sample of the
organism suspension, 0.4 µl of Taq polymerase
(Perkin-Elmer Cetus), and 10 µl of water, and the mixture was
overlaid with 50 µl of light mineral oil. Amplifications were
performed on a 96-well Perkin-Elmer thermocycler as described
previously (4). The product was separated on a 1.2% agarose
(Sigma, St. Louis, Mo.) gel that was stained with ethidium bromide. For
analysis of the band patterns, the bands were compared with a DNA
molecular size marker.
16S rRNA gene sequencing reactions.
The PCR products were
sequenced and purified by using the MicroSeq 500 Gene Kit protocols.
This DNA sequencing system uses dRhodamine-labeled dye terminators and
provides double-stranded sequence data, and the same primers used in
the PCR amplification step described above were used. Sequencing
reactions were run on a 4.5% Long Ranger (FMC BioProducts, Rockland,
Maine) and 33% urea electrophoresis gel by using an ABI Prism 377 Sequencer (PE Applied Biosystems, Foster City, Calif.). DNA sequence
data were analyzed and assembled with Auto Assembler software (PE
Applied Biosystems). Bacterial identifications based on 16S rRNA gene sequence data were assigned by using MicroSeq Microbial Identification and Analysis Software (PE Applied Biosystems).
Nucleotide sequence accession numbers.
The nucleotide
sequences of the following isolates have been submitted to GenBank
(accession numbers are given in parentheses): 5464 (AF16953), 5302 (AF16954), 5219 (AF16955), 3868 (AF16956), 3276 (AF16957), and 3075 (AF16958).
 |
RESULTS |
Figure 1 is the dendrogram based on
16S rRNA gene sequence analysis of a subset of 40 clinical "S.
milleri" group isolates selected to include representatives of
all phenotypic types. The control strains S. intermedius
ATCC 27335T, S. constellatus ATCC
27838T, and S. anginosus ATCC 9895 and 27335 are
located in the appropriate clusters. S. constellatus and
S. intermedius are more closely related to each other than
to S. anginosus and may be more homogeneous than S. anginosus. Table 1 lists some
characteristics of these isolates. Larger percentages of S. constellatus and S. intermedius isolates were isolated
from abscesses, tissues, or exudates. Within the S. anginosus cluster there was a biochemically distinct group of
urinary tract isolates. The distinct numbers for these strains (except
strain 4028-3) generated by the API 20 Strep system indicate the
ability to ferment raffinose and mannitol and, for strains 1805 and
99M2144, the ability to cleave hippurate. Although all the S. constellatus Lancefield group C isolates have Fluo-card biotype
1,2,3, which would lead to their identification as S. intermedius and most are from a gastrointestinal source, the
significance of this finding must be confirmed with additional
isolates.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 1.
Dendrogram of sequence data for 44 strains of
"S. milleri" group and other representative clinical and
type strains.
|
|
Table 2 shows the concordance of sequence
and biochemical identification for isolates within the "S.
milleri" group. All S. intermedius and S. anginosus isolates identified by sequencing were similarly
identified by biochemical analysis, but five (23%) of the S. constellatus isolates identified by sequencing were identified as
either S. anginosus or S. intermedius by our
biochemical analysis scheme. As shown in Table 2, for each of these
isolates additional enzyme activity was present (they had a Fluo-card
biotype of 2,3 or 1,2,3 instead of one of 3 alone, as expected). Part way through the study, we saw that biotypes 2,3 and 1,2,3 might be
identified as S. constellatus by sequencing, although
according to the Fluo-card instructions and previous work
(6) they should have been identified as S. anginosus or S. intermedius, respectively. We therefore
sequenced all isolates with those biotypes. We also selected isolates
with unusual phenotypes for sequencing, e.g., all Lancefield group G
isolates. Overall, 5 of 40 (13%) of the isolates were incorrectly
identified and an additional 3 of 40 (7%) of the isolates were
unidentified (the isolates did not cleave any of the substrates, and
the biotype was recorded as 0). Because all of the sequenced organisms
with biotype 3 were S. constellatus and those with biotype 2 were S. anginosus, we assigned 56 additional "S.
milleri" group strains with these biotypes accordingly. Three other strains with biotype 1 were assigned to S. intermedius. Table 3
summarizes the phenotypic characteristics associated with the isolates
identified by sequencing and all isolates. The results of CFA analysis
and Lancefield typing are similar for the same species identified by
either scheme. S. anginosus is the only species that
exhibited Lancefield type G or A.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Correspondence of cluster by sequencing and Fluo-card
identification for selected Voges-Proskauer- and arginine-positive and
sorbitol-negative streptococci
|
|
Other characteristics in Table 3 are listed for all isolates because of
the selection of unusual biotypes for sequencing. S. constellatus isolates were often associated with beta-hemolysis, S. anginosus isolates were often associated with esculin and
lactose activity and lack of beta-hemolysis, and S. constellatus and S. intermedius but not S. anginosus might have dry colonies. An important point in Table 3
is the association of specimen type or site of isolation with species.
Of our S. anginosus isolates, 43% were from blood, whereas
proportionately fewer S. constellatus and S. intermedius isolates were from blood. When we examine the
non-blood isolates, most of the S. constellatus and S. intermedius isolates are associated with upper body
abscesses or respiratory specimens (82 and 100%, respectively),
whereas most S. anginosus are associated with the
gastrointestinal or genitourinary tract or lower body abscesses (80%).
On occasion (8% of specimens), more than one "S.
milleri" group phenotype or species was isolated from the same
specimen. Two species were isolated from each of three specimens and
two hemolytic phenotypes of the same species were isolated from each of
two specimens. The sequence data in Fig. 1 show that beta-hemolytic and
alpha-hemolytic S. anginosus strains isolated from the same patient (strains 417-1 and 417-2) are different. Figure
2 shows that two strains (one
beta-hemolytic strain and one alpha-hemolytic strain) of S. constellatus isolated from the same patient (Fig. 2, lanes 8 and
9) have different rep-PCR patterns.

View larger version (75K):
[in this window]
[in a new window]
|
FIG. 2.
Two agarose gels (combined) showing the PCR products
from rep-PCR amplification. Lanes 1 to 12, 16 to 19, and 22, S. constellatus; lanes 15, and 20, and 21, S. anginosus;
lanes 13 and 14, S. intermedius. Lower and upper markers, 1 and 2 kb, respectively.
|
|
The CFA analysis results were very sensitive to growth conditions. For
example, we performed multiple analyses with 15 isolates. If the
isolates were grown on the same medium and under the same atmospheric
conditions, the runs were reproducible. However, the runs did not match
if one subculture was grown on Trypticase soy agar with blood under a
CO2 atmosphere and the other was grown anaerobically on
Columbia agar. A dendrogram based on CFA analysis of a subset of 85 streptococcal isolates grown anaerobically on Columbia agar or Columbia
CNA was made (data not shown). An arbitrary numeric was assigned to
each cluster. The number of the cluster(s) associated with each species
is shown in Table 3. Most S. constellatus and S. intermedius isolates were found in clusters 5, 6, and 9, while
most S. anginosus isolates were found in cluster 7. It is noteworthy that the S. anginosus strains from ATCC and the
strains with distinctive colony morphologies (e.g., very mucoid
colonies) did not fall in these groups. Table
4 shows that the three species have
similar CFA profiles, with S. anginosus being most distinct in the percent 14:0 CFAs. The MIDI database usually assigned the names
S. anginosus, S. pyogenes, and S. sanguis, in decreasing probabilities.
The rep-PCR analysis was not very useful. Figure 2 shows two gels
(combined) with results for representative strains. Although almost
none of the strains have exactly the same pattern, some of the S. constellatus (e.g., lanes 9 to 12 and 16 to 19) and S. anginosus (lanes 20 and 21) isolates were similar. The percentage of strains with the predominant pattern is summarized in Table 3.
 |
DISCUSSION |
Our sequence data separate the "S. milleri" group
into three species, with S. constellatus and S. intermedius being most closely related (distance matrix, 1.7%)
and S. anginosus being farther away (distance matrix,
6.8%). This confirms the relationship found by some investigators
(3, 11, 14) but not by others (7, 17). In
addition, our sequences clustered but did not distinguish at the
species level a subgroup of urinary tract isolates of S. anginosus, some of which were biochemically more active (e.g., they fermented raffinose) and which may correspond to the isolates described as separate species by Bergman et al. (3). A
subgroup of S. constellatus Lancefield group C isolates may
also be associated with gastrointestinal specimens.
We showed good agreement between the identification obtained by
sequencing and that obtained with the Fluo-card and API Strep system
combined for S. anginosus and S. intermedius
(100% for those strains that utilize the sugars in the Fluo-card).
However, in contrast to Flynn and Ruoff (6), we found
discrepancies when identifying S. constellatus. All of the
S. constellatus isolates possessed
-D-glucosidase activity, as expected, but 23% of those selected for sequencing had additional activity which led to a lack of
agreement of results. Because of these discrepant results, overall
agreement was 91%. The strains with discrepant results are similar to
those characterized as intermediate between S. constellatus
and S. intermedius (19). If the Fluo-card
interpretation criteria were changed so that isolates of Fluo-card
biotype 1,2,3 which are both beta-hemolytic and Lancefield group C were
identified as S. constellatus, then the overall
discrepancies would drop to 2%. Identification with a 32-well API
strip not commercially available in the United States may also hold
potential (1, 10).
The reported frequency of isolation of each of the species within the
"S. milleri" group is variable and seems to be at least partially a function of how the isolates were selected and how carefully they were identified. In most of the series in which species
have been assigned to the "S. milleri" group, S. anginosus is the most common isolate (1, 2, 6, 12, 13,
18). S. constellatus could be the most common isolate
in our study because of our population (essentially no women or
children and few genitourinary tract specimens), because we may have
inadvertently selected for the presence of beta-hemolysis, and/or
because fewer blood isolates were examined. All of these factors would
decrease the proportion of S. anginosus isolates. In
addition, if our data can be extended to other populations, some
S. constellatus isolates would be misidentified as S. anginosus or S. intermedius. Our data confirmed the
predominance of S. anginosus in the blood and S. constellatus and S. intermedius in abscesses (6,
12) and the distributions of hemolysis and Lancefield type among
species (13). There was a strong association of S. anginosus with a gastrointestinal or urogenital source and a
strong association of S. constellatus and S. intermedius with specimens from both upper body abscesses and the
respiratory tract.
The greater understanding achieved by correlating the 16S rRNA gene
sequence genotypic grouping with the source of isolation and careful
phenotypic description has promoted a better recognition of the niche
of S. constellatus, S. intermedius, and S. anginosus and should ultimately clarify their clinical significance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Pathology and
Laboratory Medicine Services (113), VA Medical Center and Baylor
College of Medicine, 2002 Holcombe Blvd., Houston, TX 77030. Phone:
(713) 794-7336. Fax: (713) 794-7657. E-mail: jillc{at}bcm.tmc.edu.
 |
REFERENCES |
| 1.
|
Ahmet, Z.,
M. Warren, and E. T. Houang.
1995.
Species identification of the Streptococcus milleri group isolated from the vagina by ID 32 Strep System and differential phenotypic characteristics.
J. Clin. Microbiol.
33:1592-1595[Abstract].
|
| 2.
|
Bantar, C.,
L. Fernandez Canigia,
S. Relloso,
A. Lanza,
H. Bianchini, and J. Smayevsky.
1996.
Species belonging to the "Streptococcus milleri" group: antimicrobial susceptibility and comparative prevalence in significant clinical specimens.
J. Clin. Microbiol.
34:2020-2022[Abstract].
|
| 3.
|
Bergman, S.,
M. Selig,
M. D. Collins,
J. A. E. Farrow,
E. J. Baron,
G. R. Dickersin, and K. L. Ruoff.
1995.
"Streptococcus milleri" strains displaying a gliding type of motility.
Int. J. Syst. Bacteriol.
45:235-239[Medline].
|
| 4.
|
Clarridge, J. E., III,
T. J. Raich,
D. Pirwani,
B. B. Simon,
L. Tsai,
M. Rodriguez,
R. Regnery,
A. Zollo, and C. Rambo.
1995.
A strategy to detect Bartonella infections in a routine clinical laboratory yields Bartonella henselae from a human immunodeficiency virus-positive patient and a unique Bartonella sp. from his cat.
J. Clin. Microbiol.
33:2107-2113[Abstract].
|
| 5.
|
Coykendall, A. L.,
P. M. Wesbecher, and K. B. Gustafson.
1987.
Streptococcus milleri, Streptococcus constellatus, and Streptococcus intermedius are later synonyms of Streptococcus anginosus.
Int. J. Syst. Bacteriol.
37:222-228.
|
| 6.
|
Flynn, C., and K. Ruoff.
1995.
Identification of "Streptococcus milleri" group isolates to the species level with a commercially available rapid test system.
J. Clin. Microbiol.
33:2704-2708[Abstract].
|
| 7.
|
Garnier, F.,
G. Gerbaud,
P. Courvalin, and M. Galimand.
1997.
Identification of clinically relevant viridans group streptococci to the species level by PCR.
J. Clin. Microbiol.
35:2337-2341[Abstract].
|
| 8.
|
Gomez-Garces, Jose-Luis,
J. Alos, and R. Cogollos.
1994.
Bacteriologic characteristics and antimicrobial susceptibility of 70 clinically significant isolates of Streptococcus milleri group.
Diagn. Microbiol. Infect. Dis.
19:69-73[Medline].
|
| 9.
|
Hinnebusch, C. J.,
D. M. Nikolai, and D. A. Bruckner.
1991.
Comparison of API Rapid STREP, Baxter Microscan Rapid Pos ID panel, BBL Minitek Differential Identification system, IDS RapID STR system, and Vitek GPI to conventional biochemical tests for identification of viridans streptococci.
Am. J. Clin. Pathol.
45:459-463.
|
| 10.
|
Jacobs, J. A., and E. E. Stobberignh.
1994.
Species identification of "Streptococcus milleri" with the Rapid ID 32 Strep system.
Med. Microbiol. Lett.
3:315-322.
|
| 11.
|
Jacobs, J. A.,
C. S. Schot,
A. E. Bunschoten, and L. M. Schouls.
1996.
Rapid species identification of Streptococcus milleri strains by line blot hybridization: identification of a distinct 16S rRNA population closely related to Streptococcus constellatus.
J. Clin. Microbiol.
34:1717-1721[Abstract].
|
| 12.
|
Jacobs, J. A.,
H. G. Pietersen,
E. E. Stobbringh, and P. B. Soeters.
1994.
Bacteremia involving the Streptococcus milleri group: analysis of 19 cases.
Clin. Infect. Dis.
19:704-713[Medline].
|
| 13.
|
Jacobs, J. A.,
H. G. Pietersen,
E. E. Stobbringh, and P. B. Soeters.
1995.
Streptococcus anginosus, Streptococcus constellatus, and Streptococcus intermedius: clinical relevance, hemolytic, and serologic characteristics.
Am. J. Clin. Pathol.
104:547-553[Medline].
|
| 14.
|
Knight, R. G., and D. M. Shlaes.
1988.
Physiological characteristics and deoxyribonucleic acid relatedness of Streptococcus intermedius strains.
Int. J. Syst. Bacteriol.
38:19-24.
|
| 15.
|
Ruoff, K. L.
1988.
Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen.
Clin. Microbiol. Rev.
1:102-108[Abstract/Free Full Text].
|
| 16.
|
Whiley, R. A., and D. Beighton.
1991.
Emended descriptions and recognition of Streptococcus constellatus, Streptococcus intermedius, and Streptococcus angiosus as distinct species.
Int. J. Syst. Bacteriol.
41:1-5[Medline].
|
| 17.
|
Whiley, R. A.,
B. Duke,
J. M. Hardie, and L. M. C. Hall.
1995.
Heterogeneity among 16S-23S rRNA intergenic spacers of species within the Streptococcus milleri group.
Microbiology
141:1461-1467[Abstract].
|
| 18.
|
Whiley, R. A.,
D. Beighton,
T. G. Winstanley,
H. Y. Fraser, and J. M. Hardie.
1992.
Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections.
J. Clin. Microbiol.
30:243-244[Abstract/Free Full Text].
|
| 19.
|
Whiley, R. A.,
H. Frazer,
J. M. Hardie, and D. Beighton.
1990.
Phenotypic differentiation of Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus strains within the Streptococcus milleri group.
J. Clin. Microbiol.
28:1497-1501[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, November 1999, p. 3681-3687, Vol. 37, No. 11
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.